Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 8/20 | 0.39 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16096067 | 0.87 | DRD2 (0.47) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL13238482 | 0.84 | DRD2 (0.47) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL31496727 | 0.75 | DRD2 (0.56) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL30875935 | 0.74 | ITGB3 (0.43) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL25170707 | 0.73 | DRD2 (0.55) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL21389284 | 0.73 | DRD2 (0.52) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL30737230 | 0.71 | CACNA1H (0.60) | DRD2CACNA1HSIGMAR1SUCNR1 | |
| SCHEMBL31301221 | 0.71 | DRD2 (0.55) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL513795 | 0.70 | MEN1 (0.55) | DRD2CACNA1HSIGMAR1ALDH1A1GFER | |
| SCHEMBL26452488 | 0.69 | KMT2A (0.53) | DRD2CACNA1HALDH1A1GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608454-A1 | SELF-HYDROLYZING MALEIMIDES FOR BIOCONJUGATION | Eli Lilly and Company (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092219-A1 | SELF-HYDROLYZING MALEIMIDES FOR BIOCONJUGATION | ELI LILLY AND COMPANY (US) | 2024-05-02 | — | — | WO | disclosed |